Paratek Pharmaceuticals
UEI: D5KEFN62CJ97
• CAGE: 80ES6
Overview
Awardee Type
Parent
Company Description
Patients are Our Passion. The right drugs, the right knowledge, and the right people can transform everyday decisions into everyday triumphs. Learn More.
Name
Paratek Pharmaceuticals
Website
Headquarters
Boston, MA
United States
United States
Ownership
Publicly Traded (Nasdaq:PRTK)
General Email
Most Recent Award
Dec. 18, 2019
Calculating
Federal contract recipient
PARATEK PHARMACEUTICALS, INC
(UEI D5KEFN62CJ97, CAGE 80ES6)
is headquartered in Boston MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in February 2001 and
federally registered in
December 2017.
Federal Award Analysis
Paratek Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PARATEK PHARMACEUTICALS, INC
Division Name
PARATEK PHARMA
UEI
D5KEFN62CJ97
CAGE Code
80ES6
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 27, 2001
Initial Registration
Dec. 1, 2017
Last Registration
March 31, 2025
Registration Activation
March 31, 2025
Registration Expiration
March 27, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Publicly Traded
Publicly Traded
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Paratek Pharmaceuticals
GSA Schedules and Price Lists
- Paratek Pharmaceuticals
- PoP: 7/14/19 - 2/1/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)